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OCA2 Haplotypes and Eye Color, by Duffy et al. (p.
241)
There is a great deal of evidence of an association between
pigmentation levels and skin-cancer risk. One gene that
plays a role in controlling pigmentation, OCA2, is located
in a QTL that was identified, in a genomewide linkage
scan, as being responsible for a high percentage of eye-
color variation. Additionally, OCA2 SNPs have recently
been found to be associated with eye color. Here, Duffy
et al. further examine the role of OCA2 variants in the
color of eyes, hair, and skin, as well as their relationship
with freckling and mole count. Three SNPs were found to
be associated with distinguishing blue eye color from non-
blue eye color. Also identified was a haplotype of these
three SNPs that acted as a recessive allele associated with
blue eye color and fair skin, whereas other haplotypes
acted as dominant alleles producing brown or green eyes
and darker skin. One of these SNPs was also shown to be
associated with freckling and mole count.
AAV-Mediated Gene Transfer in MoCo Deficiency,
by Ku¨gler et al. (p. 291)
Molybdenum cofactor (MoCo) is an essential cofactor for
several enzymes. When synthesis of MoCo is disrupted
because of a mutation in MOCS1, a gene encoding a mem-
ber of the MoCo biosynthesis pathway, patients experi-
ence neuronal loss and death. A mouse model for this
defect has been developed; because of Mocs1 deficiency,
these mice are unable to produce cyclic pyranopterin
monophosphate (cPMP), a precursor in MoCo biosynthe-
sis. In an effort to develop an effective treatment for MoCo
deficiency, previous work with these mice focused on sub-
stitute therapy involving the injection of purified cPMP.
Although improvements were seen, many technical dif-
ficulties existed with this course of action, so the authors,
in the present study, tried a new strategy of somatic gene
therapy to replace the missing Mocs1 gene. When new-
born mice were treated, the life span of the mice was sig-
nificantly increased, although the mice were infertile and
some did experience kidney failure. The authors then used
the gene therapy on adolescent mice that had been treated
with cPMP injections since birth. These mice were free of
abnormalities and were fertile.
Inheritance of Recombinant mtDNA, by Zsurka et
al. (p. 298)
It was generally accepted that human mtDNA does not
recombine, but there is increasing evidence that the pro-
cess does occur. The genetic consequences of this recom-
bination have been unclear, because it is not yet known
whether the recombinant mtDNA can be inherited. To
address this issue, Zsurka et al. closely examined the
mtDNA allele combinations in various tissues of heter-
oplasmic families. In each of two double-heteroplasmic
families, two members were identified who carried all four
possible pairs of the mtDNA alleles. It was proposed that
the two unexpected combinations were the products ei-
ther of recombination or of new mutations. Comparisons
of the families’ mtDNA sequences with those of mito-
chondrial databases suggested that the sites involved were
not hypermutable, so it was considered unlikely that the
new alleles arose by mutation. It was, therefore, concluded
that the presence of the four allele combinations in more
than one family member was the result of inherited re-
combinant mtDNA.
ALAD Porphyria, by Jaffe and Stith (p. 329)
ALAD (d-aminolevulinate dehydratase) porphyria is a dis-
order in which heme biosynthesis is affected because of
dysfunction of porphobilinogen synthase (PBGS). Tradi-
tionally, it was assumed that PBGS forms a homo-octamer,
but characterization of variants has demonstrated that the
protein can also assemble into a low-activity hexamer.
This conversion between isoforms is characteristic of mor-
pheeins, which are proteins that can associate into one
functional conformation and can then disassemble and
reassemble into a second functional conformation. The
two structural isoforms of PBGS are in equilibrium with
one another, and Jaffe et al. sought to determine whether
the eight mutations associated with ALAD porphyria affect
which conformation of PBGS is predominant. In compar-
ison with the wild-type protein, which existed primarily
as the octamer, five of the ALAD porphyria mutants fa-
vored the hexamer structure. An analysis of the equilib-
rium kinetics of the variants revealed that, for each, the
reaction was shifted toward the hexamer conformation.
These data helped to establish ALAD porphyria as a con-
formation disease.
A Weighted LD Score Test, by Wang and Elston (p.
353)
As the technology to gain vast amounts of data from large
case-control association studies is improving, it is becom-
ing increasingly important that the statistical methods used
to analyze these data improve as well. A common dilemma
researchers face is how best to balance the amount of in-
formation they include in their analysis with the loss of
power introduced by additional degrees of freedom. Hap-
lotype-based methods capture more information about a
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disease locus than do single SNP methods, but the phase
uncertainty leads to a loss of power. Wang and Elston
hoped to solve some of this problem by creating a statistic
based on first consolidating the information from multiple
correlated SNPs with a Fourier transform (FT). The FT com-
ponents were then combined in a weighted fashion that
accounted for the frequency of each. Comparisons with
other methods demonstrated the utility of the new method.
This Month on the Cover
In 1969, Herbert A. Lubs identified a marker X chro-
mosome in a boy who presented with mental retardation
and minor anomalies (Am J Hum Genet 21:231–244). The
marker chromosome was also found in four other male
family members who had mental retardation. The female
carriers in the family were unaffected. As shown in the
cover image, the variant chromosome was characterized
by “an unusual secondary constriction”(p234) at the end of
the q arm of X. This disorder was later dubbed “fragile X
syndrome,” and, in 1991, it was discovered that the ex-
pansion of a trinucleotide repeat within the FMR1 gene
was etiologic (Science 252:1097–1102; Science 252:1179–
1181; Cell 65:905–914; Science 252:1711–1714).
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